BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14656624)

  • 21. Histological features of acute hepatitis after imatinib mesylate treatment.
    James C; Trouette H; Marit G; Cony-Makhoul P; Mahon FX
    Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
    [No Abstract]   [Full Text] [Related]  

  • 22. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P; Das NK; Sil A; Chakrabarti P
    J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
    [No Abstract]   [Full Text] [Related]  

  • 23. Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.
    Zhao D; Wang G; Li C; Meng L
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):145-146. PubMed ID: 21336741
    [No Abstract]   [Full Text] [Related]  

  • 24. Pregnancy on imatinib: fatal outcome with meningocele.
    Choudhary DR; Mishra P; Kumar R; Mahapatra M; Choudhry VP
    Ann Oncol; 2006 Jan; 17(1):178-9. PubMed ID: 16291579
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypopigmentation from imatinib mesylate (Gleevec).
    Grossman WJ; Wilson DB
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):214. PubMed ID: 15125619
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients.
    Dora JM; Leie MA; Netto B; Fogliatto LM; Silla L; Torres F; Maia AL
    Eur J Endocrinol; 2008 May; 158(5):771-2. PubMed ID: 18426838
    [No Abstract]   [Full Text] [Related]  

  • 27. Sti571-induced Stevens-Johnson Syndrome.
    Vidal D; Puig L; Sureda A; Alomar A
    Br J Haematol; 2002 Oct; 119(1):274-5. PubMed ID: 12358937
    [No Abstract]   [Full Text] [Related]  

  • 28. Interstitial pneumonitis during imatinib therapy.
    Isshiki I; Yamaguchi K; Okamoto S
    Br J Haematol; 2004 May; 125(4):420. PubMed ID: 15142112
    [No Abstract]   [Full Text] [Related]  

  • 29. Leukemia. Q&A highlights.
    Frame D; Sessions J; Fausel C
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S22. PubMed ID: 18056929
    [No Abstract]   [Full Text] [Related]  

  • 30. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
    Georgalas I; Pavesio C; Ezra E
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1585-6. PubMed ID: 17562067
    [No Abstract]   [Full Text] [Related]  

  • 31. Imatinib for chronic myeloid leukaemia: a NICE mess.
    Lim D; Muir J
    Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
    [No Abstract]   [Full Text] [Related]  

  • 32. Pityriasis rosea associated with imatinib (STI571, Gleevec).
    Konstantopoulos K; Papadogianni A; Dimopoulou M; Kourelis C; Meletis J
    Dermatology; 2002; 205(2):172-3. PubMed ID: 12218236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy.
    Schamun A; Bullorsky E; Stemmelin G; Saxton R; Ricchione D
    Blood; 2005 Apr; 105(7):2996-7. PubMed ID: 15781911
    [No Abstract]   [Full Text] [Related]  

  • 34. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
    Pavithran K; Thomas M
    Indian J Dermatol Venereol Leprol; 2005; 71(4):288-9. PubMed ID: 16394445
    [No Abstract]   [Full Text] [Related]  

  • 35. Chlordiazepoxide for imatinib-induced muscular cramps.
    Medeiros BC; Lipton JH
    Eur J Haematol; 2006 Dec; 77(6):538. PubMed ID: 17105448
    [No Abstract]   [Full Text] [Related]  

  • 36. Imatinib mesylate (gleevec) hepatotoxicity.
    Mindikoglu AL; Regev A; Bejarano PA; Martinez EJ; Jeffers LJ; Schiff ER
    Dig Dis Sci; 2007 Feb; 52(2):598-601. PubMed ID: 17219077
    [No Abstract]   [Full Text] [Related]  

  • 37. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
    Govind Babu K; Attili VS; Bapsy PP; Anupama G
    Int Ophthalmol; 2007 Feb; 27(1):43-4. PubMed ID: 17410337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A rare complication of imatinib mesylate therapy: drug-induced pneumonitis].
    Stakhina OV; Turkina AG; Kostina IE; Kochkareva IuB
    Ter Arkh; 2010; 82(2):59-61. PubMed ID: 20387680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.
    Ikeda K; Shiga Y; Takahashi A; Kai T; Kimura H; Takeyama K; Noji H; Ogawa K; Nakamura A; Ohira H; Sato Y; Maruyama Y
    Leuk Lymphoma; 2006 Jan; 47(1):155-7. PubMed ID: 16321842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia.
    Pou M; Saval N; Vera M; Saurina A; Solé M; Cervantes F; Botey A
    Leuk Lymphoma; 2003 Jul; 44(7):1239-41. PubMed ID: 12916879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.